AMRN
AmarinCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
AMRN vs peer average
66/100
AMRN vs. peer average (C vs. D)
Grade spread
B 1 · C 3 · D 1 · F 5
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ESPR is the first available peer comparator.
Esperion — small-cap oral lipid specialist; comparable market-access, commercialization and small-cap volatility risks.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
AMRN
Amarin
ESPR
Esperion Therapeutics
Grade
C
B
Momentum
55
94
Value
41
41
Sentiment
56
45
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs ESPR
AMRN / ESPR
Grade Position
In line
AMRN vs. peer average (C vs. D)
66/100
Momentum
55
ESPRValue
41
AMRNSentiment
56
AMRNRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs AMRN
ESPR is the first peer returned for this comparison set.